SULLIVAN LARA (Chief Executive Officer) received a stock award from PYXIS ONCOLOGY, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/8/2023ACC: 0001209191-23-048814
DirectorOfficer· Chief Executive Officer
Since Oct 2021
+469.48K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
469.48K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+469.48K
Price / share
—
Trade value
—
% of position
21.8%
9/7/2023
2.16M→2.63M
Total
Net shares
+469.48K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/7/2023 | A · Award | +469.48K | — | — | 21.8% | 2.16M | 2.63M |
| Total | +469.48K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported